224
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Patient Preferences For Chemotherapy In The Treatment Of Non-Small Cell Lung Cancer: A Multicenter Discrete Choice Experiment (DCE) Study In China

, , , , , , , & show all
Pages 1701-1709 | Published online: 08 Oct 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Omer Ben-Aharon, Georgi Iskrov, Iftach Sagy & Dan Greenberg. (2023) Willingness to pay for cancer prevention, screening, diagnosis, and treatment: a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research 23:3, pages 281-295.
Read now
Candice Yong, M Janelle Cambron-Mellott, Brian Seal, Oliver Will, Martine C Maculaitis, Kelly Clapp, Emily Mulvihill, Ion Cotarla & Ranee Mehra. (2022) Patient and Caregiver Preferences for First-Line Treatments of Metastatic Non-Small Cell Lung Cancer: A Discrete Choice Experiment. Patient Preference and Adherence 16, pages 123-135.
Read now
Jelle E Bousema, Fieke Hoeijmakers, Marcel G W Dijkgraaf, Jouke T Annema, Frank J C van den Broek & M Elske van den Akker-van Marle. (2021) Patients’ Preferences Regarding Invasive Mediastinal Nodal Staging of Resectable Lung Cancer. Patient Preference and Adherence 15, pages 2185-2196.
Read now

Articles from other publishers (10)

Petros Grivas, Phani Veeranki, Kevin Chiu, Vivek Pawar, Jane Chang & Murtuza Bharmal. (2023) Preferences for first-line treatment of advanced urothelial carcinoma among US practicing oncologists and patients. Future Oncology 19:5, pages 369-383.
Crossref
Chetna Malhotra, Filipinas Bundoc, Isha Chaudhry, Irene Teo, Semra Ozdemir, Eric Finkelstein, Rebecca A. Dent, Nesaretnam Barr Kumarakulasinghe, Yin Bun Cheung, Rahul Malhotra, Ravindran Kanesvaran, Alethea Chung Pheng Yee, Noreen Chan, Huei Yaw Wu, Soh Mun Chin, Hum Yin Mei Allyn, Grace Meijuan Yang, Patricia Soek Hui Neo, Richard Harding & Lee Lai Heng. (2022) A prospective cohort study assessing aggressive interventions at the end-of-life among patients with solid metastatic cancer. BMC Palliative Care 21:1.
Crossref
Mengqian Zhang, Xiaoning He, Jing Wu, Xinyue Wang, Qian Jiang & Feng Xie. (2022) How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China. Value in Health 25:10, pages 1768-1777.
Crossref
Alene Sze Jing Yong, Yi Heng Lim, Mark Wing Loong Cheong, Ednin Hamzah & Siew Li Teoh. (2021) Willingness-to-pay for cancer treatment and outcome: a systematic review. The European Journal of Health Economics 23:6, pages 1037-1057.
Crossref
Petronella A. L. (Nelleke) Seghers, Anke Wiersma, Suzanne Festen, Mariken E. Stegmann, Pierre Soubeyran, Siri Rostoft, Shane O’Hanlon, Johanneke E. A. Portielje & Marije E. Hamaker. (2022) Patient Preferences for Treatment Outcomes in Oncology with a Focus on the Older Patient—A Systematic Review. Cancers 14:5, pages 1147.
Crossref
Hannah Collacott, Vikas Soekhai, Caitlin Thomas, Anne Brooks, Ella Brookes, Rachel Lo, Sarah Mulnick & Sebastian Heidenreich. (2021) A Systematic Review of Discrete Choice Experiments in Oncology Treatments. The Patient - Patient-Centered Outcomes Research 14:6, pages 775-790.
Crossref
Yasuo Sugitani, Kyoko Ito & Shunsuke Ono. (2021) Patient Preferences for Attributes of Chemotherapy for Lung Cancer: Discrete Choice Experiment Study in Japan. Frontiers in Pharmacology 12.
Crossref
Jelle E. Bousema, Mieke J. Aarts, Marcel G.W. Dijkgraaf, Jouke T. Annema & Frank J.C. van den Broek. (2021) Trends in mediastinal nodal staging and its impact on unforeseen N2 and survival in lung cancer. European Respiratory Journal 57:4, pages 2001549.
Crossref
Zhong Li, Peiyin Hung, Ruibo He, Xiaoming Tu, Xiaoming Li, Chengzhong Xu, Fangfang Lu, Pei Zhang & Liang Zhang. (2020) Disparities in end-of-life care, expenditures, and place of death by health insurance among cancer patients in China: a population-based, retrospective study. BMC Public Health 20:1.
Crossref
Yasuo Sugitani, Naoko Sugitani & Shunsuke Ono. (2020) Quantitative Preferences for Lung Cancer Treatment from the Patients’ Perspective: A Systematic Review. The Patient - Patient-Centered Outcomes Research 13:5, pages 521-536.
Crossref